Statement on HPV DNA test utilization

Journal of Lower Genital Tract Disease

Volumn 13, Issue 3, 2009, Pages 135-136

  Solomon, Diane ^a,d   Papillo, Jacalyn ^b   Davis Davey, Diane ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^d Executive Plaza North ^*  (United States)

Author keywords

Cervical cancer prevention; Cervical screening; HPV testing

Indexed keywords

DNA;

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; COLPOSCOPY; DNA DETERMINATION; GENOTYPE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; POSTMENOPAUSE; PRACTICE GUIDELINE; SHORT SURVEY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES AS TOPIC; UTERINE CERVICAL NEOPLASMS;

EID: 68649111618     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181a4e497     Document Type: Short Survey

References (3)

1. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362
2. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-309
3. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-222